About Timothy Springer
  • Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School.
  • He was a founding investor in publicly traded biotech outfit Moderna in 2010, investing about $5 million; he now owns 3.5% of the firm's shares.
  • Springer also owns shares in three smaller publicly traded biotech firms: Selecta Biosciences, Scholar Rock and Morphic Therapeutic.
  • He first started teaching at Harvard in 1977 as an assistant professor.
  • In 1993, he founded biotech firm LeukoSite and took it public in 1998; the next year, he sold it to Millennium Therapeutics for $635 million.
Wealth History
HOVER TO REVEAL NET WORTH BY YEAR

Forbes Lists

#176
Forbes 400 (2021)Dropped off in 2022
Personal Stats
Age
76
Source of Wealth
Biotech, Self Made
Self-Made Score
8
Philanthropy Score
1
Residence
Chestnut Hill, Massachusetts
Citizenship
United States
Marital Status
Married
Education
Ph.D, Harvard University; Bachelor of Science, University of California, Berkeley
Did you know
In 2017, Springer established the Institute for Protein Innovation, an independent nonprofit focused on researching proteins, with an initial grant of $10 million.
Springer bikes to work from his home in Chestnut Hill, Massachusetts.
Related People & Companies
Moderna
Moderna
Holds stake in Moderna
View Profile
Noubar Afeyan
Noubar Afeyan
Business Associate
View Profile
Boston, MA
Boston, MA
Resides in Boston, MA Metropolitan Area
View Profile

More on Forbes